Conn P M, Rogers D C, Sheffield T
Endocrinology. 1981 Oct;109(4):1122-6. doi: 10.1210/endo-109-4-1122.
In the present work, we show that pimozide is a noncompetitive antagonist of gonadotropin-releasing hormone (GnRH)-stimulated LH release from pituitary cell cultures. For several other neurotropic agents, the concentration needed to inhibit 50% of LH release in response to GnRH correlates well with the ability to inhibit enzyme activation by calmodulin in vitro. Pimozide does not alter the affinity or amount of releasing hormone binding by the GnRH receptor. The additional observation that pimozide inhibits Ca2+ ionophore (A23187 and ionomycin)-stimulated LH release suggests that the locus of pimozide action is after Ca2+ mobilization. Pimozide is known to bind and inactivate the Ca2+-calmodulin complex, and as Ca2+ is a second messenger for GnRH, it is possible that calmodulin is the target of pimozide in this system.
在本研究中,我们发现匹莫齐特是促性腺激素释放激素(GnRH)刺激垂体细胞培养物中促黄体生成素(LH)释放的非竞争性拮抗剂。对于其他几种嗜神经药物,抑制50% GnRH诱导的LH释放所需的浓度与体外抑制钙调蛋白激活酶的能力密切相关。匹莫齐特不会改变GnRH受体结合释放激素的亲和力或数量。另外观察到匹莫齐特抑制钙离子载体(A23187和离子霉素)刺激的LH释放,这表明匹莫齐特的作用位点在钙离子动员之后。已知匹莫齐特能结合并使Ca2+-钙调蛋白复合物失活,由于Ca2+是GnRH的第二信使,因此钙调蛋白可能是该系统中匹莫齐特的作用靶点。